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Abstract: In this study, we develop and present a deterministic model for the transmission dynamics
of methicillin-resistant staphylococcus aureus (MRSA) among injection drug users. The model consists
of non-injection drug users as well as low-and high-risk injection drug users (IDUs). The model
further incorporates the movement of these individuals between large metro, suburban and rural
areas. The model parameters were estimated by fitting the model to the 2008–2013 disease prevalence
data for non-IDUs obtained from the Agency for Healthcare and Research and Quality (AHRQ),
as well as the 2009–2013 Census Bureau data for the number of individuals migrating between three
different counties in Kansas. Sensitivity analysis was implemented to determine the parameters with
the most significant impact on the total number of infected individuals; the transmission probability,
recovery rates, and positive behavioral change parameter for the subgroup have the most significant
effect on the number of infected individuals. Furthermore, the sensitivity of the parameters in
the different areas was the same when the areas are disconnected. When the areas are connected,
the parameters in large-metro areas were the most sensitive, and the rural areas were least sensitive.
The result shows that to effectively control the disease across the large metro, suburban and rural
areas, it is best to focus on controlling both behavior and disease in the large metro area as this has
a trickle-down effect to the other places. However, controlling behavior and disease at the same time
in all the areas will lead to the elimination of the disease.
Keywords: MRSA; injection drug users; mobility; sensitivity analysis; control strategies
1. Introduction
Methicillin-resistant staphylococcus aureus (MRSA) is a bacteria resistant to antibiotics, particularly
methicillin. It affects the subcutaneous tissue of the skin and often starts as a painful red bump that
looks like a pimple or a spider bite. MRSA is difficult to treat due to its resistance to traditional
antibiotics used in the treatment of Staph infections [1,2]; it can equally be deadly. The occurrence
of MRSA started in 1960 just after two years of using it as a viable and effective treatment for
methicillin-susceptible staphylococcus aureus.
MRSA is transmitted when a healthy individual comes in direct contact with an infected person
with an open wound or an infected tissue or secretions. It can also be contracted indirectly from
contaminated surfaces, objects, or materials contaminated with the bacteria by an infected person;
the contaminated fomites can remain infectious for months [3]. A healthy individual becomes colonized
with the bacteria until the MRSA bacteria finds an opportunity to infect the soft tissue of the skin [4].
Substance abuse, including drug abuse, is a cultural and public health problem affecting many
millions of persons in the United States [5]. “Drug addiction is a complex health disorder characterized
by its chronic and relapsing nature” [6]; it is preventable and treatable, and it is not due to any moral
or societal failure or a criminal behavior [6].
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MRSA is endemic among injection drug users (IDUs), its spread in the community started in 1981
and has since persisted in the community [4]. Some of the research studies on MRSA among IDUs
are usually carried out by tracking the registered IDUs [7–10]. For example, Fleisch et al. [9] in their
study followed 31 MRSA infected IDUs from August of 1994 to December 1999; they found that 19 of
these individuals developed secondary, life-threatening ailments such as septic arthritis, endocarditis,
pneumonia, and osteomyelitis. In another study, Binswanger et al. [8] found that 29 individuals
displayed subcutaneous inflammation and infection from a study involving 169 IDUs.
Injection drug users present a unique set of behavioral factors that all accumulate to increase
the risk of MRSA transmission and infection. For instance, Kretzschmar [10] found that 12% of the
494 IDUs in their study were HIV-positive while only 1.5% of 207 non-IDUs were HIV-positive and
they concluded that HIV among these IDUs was not likely sexually transmitted [10]. In recent times,
there has been an increase in the proportion of invasive MRSA cases among IDUs due to the use of
non-sterile injection drug another risky behavior engaged by IDUs [11]. The number of IDUs increased
from 4.1% in 2011 to 9.2% in 2016 [11]. Furthermore, IDUs are 16.3 times more likely to develop
invasive MRSA infections than others [11].
Demographic studies of illicit drug use found a higher occurrence of illicit drug uses in large
metropolitan populations [12]. The Department of Health and Human Services defined a large
metropolitan area in their 2015 national survey of drug use and health as an area having a population
greater than one million [13]. According to the Department, 8.3% of the individuals living in large
metropolitan areas used drugs in the past month of the survey, followed by 8.2% of the populations
living in small metropolitan areas with only 4.2% in rural areas [13]. In 2010 National Institute on Drug
Abuse found very large cities (population over 500,000) have a higher lifetime prevalence of drug use at
64.9% of drug users followed by 63.7% in large cities (population of 100,000–500,000), 59.3% in medium
cities [12]. According to the National Survey on Drug Use and Health (NSDUH) survey, the lifetime
use of illicit drugs in large and small metropolitan areas was 113,967 while non-metropolitan areas
were 16,644. These statistics bring to the light the great need for action in drug abuse interventions in
cities, particularly in the metropolitan areas.
The goals in this paper are to determine the impact of movement on the control of MRSA when
the communities are isolated and connected, and to also understand the effect of movement on drug
rehabilitation programs and intervention as a means of controlling risky behaviors among IDUs when
in isolated and connected communities. To achieve our goals, we extend the deterministic model
in [14] to include multiple patches and movement between these patches.
This paper is organized as follows: In Section 2, we present the MRSA transmission model and
carry out a theoretical study of its basic properties in Appendix A. In Section 2.2 we estimate the
movement parameter values; values of the other model parameters are given in [14]. In Section 3,
sensitivity analysis was carried out to identify the parameters that have significant impact on the
model’s response function: The total number of infectious individuals in the community. In Section 4,
we use the results obtained from the sensitivity analysis to investigate the impact of movement on
both disease and behavioral controls in connected and isolated communities. The research discussions
and conclusions are given in Sections 5 and 6 respectively.
2. Model Formulation
To model the disease transmission, we consider MRSA transmission in three different areas namely
large metropolitan, suburban, and rural areas. We developed a deterministic model for the transmission
when these areas are connected. We use the deterministic model developed in [14] and extend it by
including the movement of individuals between these connected areas. The methicillin-resistant
Staphylococcus aureus transmission model among injection drug users divides individuals in the
community into three subgroups, non-drug users, low-risk IDUs, and high-risk IDUs. The low-risk
IDUs use drugs at a limited to moderate level, while high-risk IDUs are intense to severe drug
users [14]. Each of these population subgroups is further divided into three compartments according to
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their disease status; namely uncolonized susceptible individuals (Uj), colonized individuals (Cj),
and infected individuals (Ij), where j = Ni, Li, Hi for non-injection drug users, low-risk IDUs,
and high-risk IDUs and i = M, S, R for large metropolitan, suburban, and rural areas, respectively.
These lead to the following total population.
Ni = UNi + CNi + INi + ULi + CLi + ILi + UHi + CHi + IHi ,
The MRSA transmission dynamics with IDUs and mobility within three different areas is given
by the following system of ordinary differential equations
dUNi
dt
= πNi + αLi ULi + τNi CNi + γNi INi − λNi UNi − k1i UNi−
R
∑
j=S, j 6=i
ψijUNi +
R
∑
j=S, j 6=i
ψjiUNi (1)
dCNi
dt
= αLiCLi + λNiUNi − τNiCNi − k2i CNi−
R
∑
j=S, j 6=i
ψijCNi+
R
∑
j=S, j 6=i
ψjiCNi
dINi
dt
= αLi ILi + σNiCNi − k3i INi−
R
∑
j=S, j 6=i
ψij INi+
R
∑
j=S, j 6=i
ψji INi
dULi
dt
= πLi + ωNiUNi + αHiUHi + τLiCLi + γLi ILi − λLiULi − k4i ULi−
R
∑
j=S, j 6=i
ψijULi+
R
∑
j=S, j 6=i
ψjiULi
dCLi
dt
= ωNiCNi + αHiCHi + λLiULi − τLiCLi − k5i CLi−
R
∑
j=S, j 6=i
ψijCLi+
R
∑
j=S, j 6=i
ψjiCLi
dILi
dt
= ωNi INi + αHi IHi + σLiCLi − k6i ILi−
R
∑
j=S, j 6=i
ψij ILi+
R
∑
j=S, j 6=i
ψji ILi
dUHi
dt
= πHi + ωLi ULi + τHi CHi + γHi IHi − λHi UHi − k7i UHi −
R
∑
j=S, j 6=i
ψijUHi +
R
∑
j=S, j 6=i
ψjiUHi
dCHi
dt
= ωLi CLi + λHi UHi − τHi CHi − k8i CHi−
R
∑
j=S, j 6=i
ψijCHi+
R
∑
j=S, j 6=i
ψjiCHi (2)
dIHi
dt
= ωLi ILi + σHi CHi − k9i IHi−
R
∑
j=S, j 6=i
ψij IHi+
R
∑
j=S, j 6=i
ψji IHi
where
k1i = ωNi + µi, k2i = ωNi + σNi + µi, k3i = ωNi + γNi + µi + δNi
k4i = ωLi + αLi + µi, k5i = ωLi + αLi + σLi + µi, k6i = ωLi + αLi + γLi + µi + δLi
k7i = αHi + µi, k8i = αHi + σHi + µi, k9i = αHi + γHi + µi + δHi .
and i = M, S, R for the different areas, i.e., large metropolitan, suburban, and rural communities.
The flow diagram for the model is depicted in Figure 1 for a single patch i. The associated model
variables and parameters are described in Table 1.
The parameter πNi is the recruitment rate into the uncolonized non-injection drug users (UNi )
subgroup for a particular area or patch i. The parameter µ is the natural death rate in each
subpopulation in patch i. The force of infection of the non-injection drug users in patch i is given by
λXi =
βXi (CNi + INi + CLi + ILi + CHi + IHi )
Ni
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where, X = N, L, H for the different subgroups according to their behavior (i.e., non IDUs, low-and
high-risk IDUs) and the parameter βNi is the probability in patch i of an uncolonized individual
becoming colonized following exposure to the MRSA bacteria through contact with colonized and
infected individuals in either the non-injection drug users class or the low-risk class or the high-risk
class. Colonized individuals in patch i are decontaminated at the rate τNi [15], after which they move
back to the uncolonized class. However, as the disease progresses the colonized non-drug users (CNi )
in patch i move to the infected class at rate σNi . Infected individuals (INi ) recover at the rate γNi and
thus move to the uncolonize class (UNi ). The model does not include recovered compartment since
there is no immunity associated with the infection. The parameters and transitions for the low-risk
and high-risk populations in patch i are similarly defined (with the subscript Ni replaced by Li and
Hi respectively).
If non-drug users in patch i engage in risky behavior resulting in injection drug use, we assume
that these individuals will initially start small with less frequent and less risky behavior and drug use;
therefore, these individuals will move into the low-risk IDU subgroup from the non-drug user subgroup
at rate ωNi . However, these individuals can decrease these risky behaviors either by timely family
interventions or by enrolling in drug rehabilitation programs [7,16] or by other kinds of interventions;
when this happens, they go back to the non-drug user subgroup at the rate αLi .
Individuals in the low-risk subgroup in patch i might progress and become high-risk injection drug
users due to their persistent engagement in these risky behaviors, thereby moving into the high-risk
IDUs subgroup at the rate ωLi . As with the low-risk individual, these individuals may stop injecting
drugs when they enter a drug rehabilitation program or utilizing needle exchange programs [7,16].
We assume these disease and behavioral processes are not instantaneous but rather a gradual process;
hence these individuals due to their behavior first enter the low-risk subgroup at rate αHi .
Note that patch i refer to either large metropolitan, suburban or rural areas. We will investigate
the effect of movement on both behavior and disease controls when these patches are either connected
or isolated.
Figure 1. Flow diagram of the Methicillin-resistant staphylococcus aureus (MRSA) model Equation (1)
with injection drug users (IDUs) in a single patch.
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Table 1. Variable and Parameter descriptions for the MRSA model Equation (1) per day.
Variable Description
UNi , ULi , UHi Population of uncolonized non-IDUs, low-risk IDUs, and high-risk IDUs in patch i
CNi , CLi , CHi Population of colonized non-IDUs, low-risk IDUs, and high-risk IDUs in patch i
INi , ILi , IHi Population of infected non-IDUs, low-risk IDUs, and high-risk IDUs in patch i
Parameter Description
πNi , πLi , πHi Natural birth rate
βNi , βLi , βHi Transmission probability per contact with colonized or infected population
σNi , σLi , σHi Progression rate of colonized population
γNi , γLi , γHi Recovery rate of infected population
τNi , τLi , τHi Decolonization rate of colonized population
ωNi , ωLi , ωHi Increased IDU risk behavior
αNi , αLi , αHi Decreased IDU risk behavior
µi Natural death rate
δNi , δLi , δHi Death rate due to disease
2.1. Reproductive NumberR0
The basic reproductive number,R0, is given by the result of the expression
R0 = ρ(FV−1).
where ρ is the spectral radius.
The basic reproductive number,R0, is the average number of secondary infections produced by one
infectious individual introduced into a wholly susceptible population [17–20]. IfR0 < 1, MRSA will die
out in the community, and ifR0 > 1, MRSA it will persist and become endemic. The epidemiological
implication of this result is that it will be possible to eliminate MRSA from the community provided the
reproduction number (R0) is brought to (and maintained at) value less than one.
The theoretical study of the basic quantitative properties of the model are presented in
Appendix A.1, and the derivation of the expression of basic reproductive number, R0, are given
in Appendix A.2.
2.2. Model Parameter Estimation
2.2.1. MRSA Demographic Data from 2008–2013
To parameterize the MRSA model in [14], we used the 2008–2013 demographic data obtained from
the Agency for Healthcare and Research and Quality (AHRQ) [21]. AHRQ compiles discharge data
from hospitals throughout the United States; this data is classified as the International Classification of
Diseases (ICD-9). Any patients discharged with the MRSA are recorded with ICD-9 code. To obtain
the MRSA data from AHRQ discharge data, we set the demographic targets to look at large metro,
large suburb, and rural areas. The large metropolitan population produced the highest number of
patients with MRSA listed on their medical records upon discharge. Figure 2 displays the data in tens
of thousands of hospital discharges.
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Figure 2. Demographic data from three regional areas, large metro, large suburb, and rural. Large
metropolitan data gives the highest number of MRSA patients discharged with MRSA ICD-9 code
listed on their medical record in the magnitude of tens of thousands.
2.2.2. Parameter Estimation
The parameters in the single patch model in [14] of the MRSA model Equation (1) was obtained
using a reduced model involving only the non-IDUs. The ICD-9 MRSA data for large metro, rural,
and suburb regional areas was used to estimate the parameters. The results are given in Table 2;
the model simulation profile and the fitted data are depicted in Figure 3.
To obtain the parameter estimates for the IDUs subgroups in the full MRSA model Equation (1)
for a single patch, we follow the approach in [14] and multiplied the non-IDUs subgroup parameter
estimates βNi , γNi , and σNi by modifying parameters εL and εH representing low-risk and high-risk
subgroups. These risk factors (modification parameters) listed in Table 3 enable us to determine an
estimate away (either in an increasing or decreasing form) from the non-IDUs parameters. Their
derivation is given in [14]. It is possible to also estimate the risk factors using addiction severity
score [22]. We assume that the values of the parameters in each subgroup are the same for the three
different areas we are considering.
Table 2. Parameter estimation of the non-injection drug users reduced MRSA model given in [14] using
regional data.
Variable Large Metro Rural Suburb
βN 0.2895 0.2015 0.1444
γN 0.2778 0.1874 0.1316
σN 0.7079 0.6670 0.6560
Table 3. Complementary table displaying and quantifying injection drug user risk associated behaviors.
Each rate value (0–5) is equal to % risk factor value. (i.e., rating value of 7 = 42% risk factor).
Rating Class Assignment Risk Factor Limits (%)
0 non-injection drug user 0
1–6 low-risk injection drug user 6–36
7–15 high-risk injection drug user 42–90
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(a) (b)
(c)
Figure 3. Simulation of the non-IDUs reduced MRSA model given in Wagner [14] was fitted to the
ICD-9 MRSA data for: (a) Large metropolitan data; (b) large suburbs area data; (c) rural area data.
2.2.3. Estimation of the Movement Rates ψij and ψji
To estimate the movement rates ψij and ψji, we focus on the number of people migrating between
three counties in Kansas, namely Shawnee, Douglass, and Jefferson counties. These counties were
chosen to represent the Large metropolitan, suburban and rural areas. Although the sizes of these
counties are smaller than the size of the metropolitan area defined by the Department of Health and
Human Services in Section 1 which puts the size of a large metro as a million. Nevertheless, the result
and conclusion are not expected to deviate from the result obtained if we have used a larger population
size. The population in these counties (Shawnee, Douglass, and Jefferson counties) from 2009–2013
according to the Census Bureau 2009–2013 data are 175,136, 110,973, and or 18,947, respectively. This
period was used to match with the time range of the MRSA discharged data used to estimate the
disease parameters. We have not included 2008 in this time range because the Census Bureau estimate
of the gross number migrating for 2008 overlaps with other time range and cannot be tease apart.
Nevertheless, we believe the 2009–2013 estimate is a good estimate for the entire 2008–2013 time
range. The number of people migrating between these counties over this period was obtained from the
county-to-county 2009–2013 ins-outs-nets-gross migration data from the Census Bureau [23]. Table 4
shows the number of individual migrating between each county. The migration rate is obtained by
dividing the number of individuals migrating by the total population in each county, see Table 5 and
Figure 4. Figure 4 shows more people moving to the Shawnee county from Douglas, and Jefferson
counties; furthermore, more people move to Shawnee than Douglas from Jefferson. However, fewer
people migrate in the opposite direction from the larger counties to Jefferson.
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Table 4. Census Bureau county-to-county 2009–2013 ins-outs-nets-gross number migrating in Shawnee,
Douglas, and Jefferson counties [23].
Counties Shawnee Douglas Jefferson
Shawnee - 1291 578
Douglas 1291 - 511
Jefferson 578 511 -
Table 5. County-to-county 2009–2013 ins-outs-nets-gross migration rate in Shawnee, Douglas,
and Jefferson counties.
Counties Shawnee Douglas Jefferson
Shawnee - 0.0074 0.0033
Douglas 0.0116 - 0.0046
Jefferson 0.0305 0.0270 -
Figure 4. Movement rates within the regions.
.
3. Sensitivity Analysis
Outputs from deterministic models are governed by their input parameters, which often exhibit
some level of uncertainty in the process of their selection. Exploration of the MRSA model Equation
(1) above requires the identification of parameters which significantly affect the number of infected
individuals (the key model outputs). To assess the impact of the input parameters uncertainty and the
sensitivity of the key model outputs from the numerical simulations to variations in each parameter,
we carried out a global sensitivity analysis using Latin Hypercube Sampling (LHS) and partial rank
correlation coefficients (PRCC).
The LHS is a stratified sampling technique without replacement; it allows for an efficient analysis
of parameter variations across simultaneous uncertainty ranges in each parameter [24–27]. The PRCC
method measures the strength of the relationship between the parameters and the model outcome.
It gives the degree to which each parameter affects the model outcome [24–27].
To generate the LHS matrices, we assume a uniform distribution for all the model parameters.
We then carried out a total of 1000 simulations (runs) of the models for the LHS matrix, using the
parameter values given in Tables 2 and 3 (with ranges varying from ±20% the stated baseline values)
and as response functions, the sum of carriers and infected in each region for the isolated case; for the
connected case, the response function is the sum of the carriers and infected across the regions.
These simulation runs were followed by the parameter ranking using PRCC.
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The most significant parameters with the largest impact on the model outcome examined under
each analysis have the largest partial rank correlation coefficient (PRCC) values. The parameters with
positive PRCC values have a positive impact on the number of infected and increase in their values
will lead to an increase in the number of infected. While the parameters with negative PRCC values
will reduce the number of infected due to their negative impact on the carriers and infected individuals
in the population.
The key parameters with negative PRCC values when the regions are isolated are αHM, γHM,
γLM, γNM, αLM, γHS, γLS and αHS. While those with positive PRCC values are σHM, βHM,
βLM, βNM, βHS, βLS, ωHM, ωLM, and ωLS. It is interesting to note that the PRCC values are the
same in all the patches when the patches are in isolation, see Figure 5.
Figure 5. Partial rank correlation coefficient (PRCC) values of the MRSA model using as response
function infected individuals when the patches (large metropolitan, suburban, and rural areas) are
isolated. Parameter values used are given in Tables 2–4.
Figure 6 depict the PRCC values when the regions are connected. The key parameters with negative
PRCC values are αHM, γHM, γLM, γNM, αLM, γHS, γLS and αHS. While those with positive PRCC
values are σHM, βHM, βLM, βNM, βHS, βLS, ωHM, ωLM, and ωLS. Under this case, the PRCC values
are higher in the large metro area followed by the suburban area, the rural area have the lease values.
This is due to the high movement rates into the large metro areas compare to the other two areas.
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Figure 6. Partial rank correlation coefficient (PRCC) values of the MRSA model using as response function
infected individuals when the regions (metro, suburban, and rural areas) are connected. Parameter values
used are given in Tables 2–4.
4. Control Measures
In this section we considered two types of control strategies; the first strategy in Section 4.1
investigates the impact of controlling an individual’s risky behaviors which promotes injection drug
use via the vertical downward movement parameters ωN and ωL, and the enrollment in rehabilitation
programs via the vertical upward movement parameters αL and αH . The second strategy in Section 4.2
investigates the control of the disease in the community using results of the highly effective strategy
identified in [14]. For the two different control strategies either control of risky behavior or disease,
we used the intermediate risk factor values εL = 21% and εH = 66 % as was done in [14].
4.1. Control of Risky Injection Drug Use Behaviors
In this section, we investigate the impact of behavioral change due to vertical downward and
upward movements between the sub-groups from risky behaviors that promote (upward movement)
and discourages (downward movement) injection drug use in the community. Note, our focus here is
to control the risky behaviors and not MRSA transmission within the subgroups of the different areas.
We set the baseline behavioral downward and upward movements parameters as ωN = 0.05825,
ωL = 0.116, αL = 0.0112, αH = 0.0560. Since we are interest in investigating the effect of behavioral
control, on movement between the patches, we decrease the risky behavior by 2 and double the positive
behavior. Thus, we set the behavioral parameters as ωN = 0.05825/2, ωL = 0.116/2, αL = 0.0112× 2,
αH = 0.0560× 2.
4.1.1. Behavioral Control When Patches Are Isolated
We start by considering the case where the patches are in isolation. We observe in Figure 7
a reduction in the number of cases in each of the patches. We have normalized the number infected
for proper comparison between the patches. We observed further from the figure an equal number of
Antibiotics 2019, 8, 81 11 of 26
infected individuals regardless of the patch size. Table 6 gives the proportion of infected individuals at
the end of the simulation period.
(a) (b) (c)
Figure 7. MRSA model simulation with no movement. (a) Infected individuals in large metro area,
(b) Infected individuals in suburban area. (c) Infected individuals in rural area. Parameter values used
are given in Tables 2 and 3.
Table 6. Proportion of infected individuals at the end of simulation period when controlling behavior
in isolated patches.
Regions Without Control With Control
Metro 0.7440 0.4066
Suburban 0.7610 0.4137
Rural 0.7735 0.4176
4.1.2. Behavioral Control in a Patch One at a Time When the Patches are Connected
Under this scenario, the patches are connected, and behavioral control is implemented in a patch
one at a time. By behavioral control, we mean discouraging risky behavior and encouraging IDUs to
either practice safe needle use or to enter rehabilitation centers. In Figure 8a–c, the control is in the
Large metro area only, and we observed a reduction in the proportion of infected individuals; however,
this number is more than when the patch is isolated (compare Tables 6 and 7). In addion, we observed
that controlling behavior in large metropolitan area leads to a decrease to some extent in the number
of infected individuals in the suburban and rural. However, the effect is stronger in the rural area than
the suburban. We observed similar dynamics in Figure 8d–f when we are controlling behavior in the
suburban patch. This, however, is not the case when we control behavior in the rural area; we see
a negligible effect in the patches with large population even though more people move into these
patches from the rural area, see Figure 8g–i, Table 7 gives the proportion of infected at the end of the
simulation period.
The negligible effect of the control might be due to the fact that the number of individuals coming
in from the rural area to the larger populated areas (large metropolitan and suburban areas) is small in
comparison to the overall population size in the larger areas, even though the rate from rural area is
higher (see Figure 4). As a result, their overall influence might be weak. This study have not looked at
the effect of super-spreaders or influencers, we have assumed that every individual in the community
have the same global effect. This will be an interesting future work to consider.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 8. MRSA model simulation with movement and behavioral control in large metro area only
(a–c). Movement and behavioral control in suburban area only (d–f). Movement and behavioral control
in rural area only (g–i). (a) Infected individuals in large metro area. (b) Infected individuals in suburban
area. (c) Infected individuals in rural area. (d) Infected individuals in large metro area. (e) Infected
individuals in suburban area. (f) Infected individuals in rural area,=. (g) Infected individuals in large
metro area. (h) Infected individuals in suburban area. (i) Infected individuals in rural area. Parameter
values used are given in Tables 2–4.
Table 7. Final population size when controlling behavior one at a time when the regions are connected.
Regions Without Control With Control in With Control in With Control inMetro Area Suburban Area Rural Area
Metro 0.7442 0.4539 0.7119 0.7352
Suburban 0.7608 0.7061 0.4939 0.7486
Rural 0.7720 0.6693 0.6895 0.6230
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4.2. Control of MRSA Transmission
In this section, we investigate the impact of controlling MRSA transmission within the subgroups
when the patches are isolated and when they are connected. To do this, we use results obtained
from the sensitivity analysis (see also [14]). For the sensitivity analysis we obtained control strategies
that reduce βNi and increase γNi , i = M, S, R, will impact MRSA in the community, since these
parameters have strong positive (βNi ) and negative (γNi ) impact on the number of infected; the same
holds for the parameters βLi , βHi , γLi , and γHi . In [14], three different strategies were implemented
namely low-effectiveness strategy, moderate-effectiveness strategy, and high-effectiveness strategy
and it was concluded in [14] that the high-effectiveness strategy did the best in reducing infection in
the community. In this study, we focus on the high-effectiveness strategy and set in each patch the
following disease-related parameters as
βNi = βNi /4, γNi = (1 + 0.009)γNi , i = M, S, R
βLi = βNi (1 + εL), βHi = βNi (1 + εH)
γLi = γNi (1− εL), γHi = γNi (1− εH).
4.2.1. MRSA Control When the Patches Are Isolated
Considering the scenario when the patches are in isolation, we observe a substantial reduction in
the number of cases in each of the patches (see Figure 9 and Table 7). The level of reduction is the same
in each patch regardless of the patch size, and it’s more than when controlling behavior in the isolated
patches case, see Tables 6 and 7 for the proportion infected at the end of the simulation period.
(a) (b) (c)
Figure 9. MRSA model simulation with no movement. (a) Infected individuals in large metro area,
(b) Infected individuals in suburban area. (c) Infected individuals in rural area. Parameter values used
are given in Tables 2–4.
Table 8. Final population size when controlling MRSA when the regions are Isolated.
Regions Without Control With Control
Metro 0.7440 0.1959
Suburban 0.7610 0.1979
Rural 0.7735 0.1924
4.2.2. MRSA Control in a Patch One at a Time When the Patches Are Connected
Next, we consider the case where the disease is controlled one at a time when the patches are
connected. We see in Figure 10a substantial reduction in infection level in the individual patch where
the control is being implemented. The reduction is not as much as what we see when they are isolated
(compare Tables 8 and 9). Furthermore, the effect of the control in either the metro or suburban area
is negligible when the control is in either place and slightly more when in the rural area, see Table 9.
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For instance, when the control is implemented in the large metro area, we see a smaller reduction in the
number of infected in the suburban area compare to the number in the large metro and rural areas. This
is because the rate at which people are moving to the metro from the suburban is higher than the rate
at which they are moving from the metro to the suburban see Figure 4, and their population (metro
and suburban) is relatively comparable in size. In addition, the rate at which people move to the metro
from the rural area is higher than the rate from the metro to the rural; when converted to numbers,
we see that more people actually move from the metro to the rural area than those that move from
the rural area to the metro; this is the reason why the effect of the control in large metropolitan area is
felt more in the rural area. In addition, the control of the disease in the rural area have no effect in the
larger patches.
Table 9. Final population size when controlling MRSA one at a time when the regions are connected.
Regions Without Control With Control in With Control in With Control inMetro Area Suburban Area Rural Area
Metro 0.7442 0.3095 0.7345 0.7419
Suburban 0.7608 0.7363 0.3854 0.7566
Rural 0.7720 0.6999 0.7191 0.5709
(a) (b) (c)
(d) (e) (f)
Figure 10. Cont.
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(g) (h) (i)
Figure 10. MRSA model simulation with movement, disease, and behavioral control in large metro
area only (a–c). Movement, disease, and behavioral control in suburban area only (d–f). Movement,
disease, and behavioral control in rural area only (g–i). (a) Infected individuals in the large metro area.
(b) Infected individuals in the suburban area. (c) Infected individuals in the rural area. (d) Infected
individuals in the large metro area. (e) Infected individuals in the suburban area. (f) Infected individuals
in the rural area. (g) Infected individuals in the large metro area. (h) Infected individuals in the
suburban area. (i) Infected individuals in the rural area. Parameter values used are given in Tables 2–4.
4.3. MRSA and Behavioral Controls
In this section, we investigate the effect of controlling both behavior and disease transmission
at the same time when the patches are isolated and when they are connected. We set the behavioral
parameters as ωN = 0.05825/2, ωL = 0.116/2, αL = 0.0112× 2, αH = 0.0560× 2, and the disease
parameters as
βNi = βNi /4, γNi = (1 + 0.009)γNi
βLi = βNi (1 + εL), βHi = βNi (1 + εH)
γLi = γNi (1− εL), γHi = γNi (1− εH).
4.3.1. MRSA and Behavioral Control in Isolated Patches
We start with the case when the patches are isolated, and we are controlling both behavior and
disease transmission. We see in Figure 11 that the disease is just about eliminated, with very low
infection levels. This, of course, happens in all the three isolated patches.
(a) (b) (c)
Figure 11. MRSA model simulation with movement, disease and behavioral control in large metro area
only. (a) Infected individuals in large metro area. (b) Infected individuals in suburban area. (c) Infected
individuals in rural area. Parameter values used are given in Tables 2–4.
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4.3.2. MRSA and Behavioral Control in a Patch One at a Time in Connected Patches
Next, we consider the case when the patches are connected, and both behavior and disease are
being controlled in the patches one at a time. We observed under this scenario a significant reduction
in the number of infected in both large metropolitan and suburban when control is implemented in
either place. The proportion of infected is more than what was obtained when the patches are in
isolation. Their effect on each other (large metro and suburban areas) is not as strong as with isolated
patches. This effect carries through to the rural area as well with the control in the large metropolitan
area having a stronger effect than the control in the suburban area, see Figure 12 and Table 10.
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 12. MRSA model simulation with movement, disease, and behavioral control in large metro
area only (a–c). Movement, disease, and behavioral control in suburban area only (d–f). Movement,
disease, and behavioral control in rural area only (g–i). (a) Infected individuals in large metro area.
(b) Infected individuals in suburban area. (c) Infected individuals in rural area. (d) Infected individuals
in large metro area. (e) Infected individuals in suburban area. (f) Infected individuals in rural area.
(g) Infected individuals in large metro area. (h) Infected individuals in suburban area. (i) Infected
individuals in rural area. Parameter values used are given in Tables 2–4.
Antibiotics 2019, 8, 81 17 of 26
On the other hand, when the control is implemented in the rural area, the effect on the large metro
and suburban areas is negligible. Although we are able to reduce the number of infection in the rural
area under this strategy; the reduction is not as low as what was obtained under the isolated case.
Table 10. Final population size when controlling MRSA & Behavior one ar a time when the regions
are connected.
Regions Without Control With Control in With Control in With Control inMetro Area Suburban Area Rural Area
Metro 0.7442 0.0897 0.7029 0.7330
Suburban 0.7608 0.6825 0.1656 0.7446
Rural 0.7720 0.5962 0.6364 0.4366
4.4. MRSA and Behavioral Control in Connected Patches
Lastly, under this scenario, we implement both behavior and disease control when the region is
connected, and we see in Figure 13 an elimination of the disease across the three patches.
(a) (b) (c)
Figure 13. MRSA model simulation with movement, disease and behavioral control in large metro area
only. (a) Infected individuals in large metro area. (b) Infected individuals in suburban area. (c) Infected
individuals in rural area. Parameter values used are given in Tables 2–4.
5. Discussion
In this study, we extended the model developed in [14] to include the movement of individuals
between different patches (metropolitan, suburban, and rural areas). The model further includes the
movement of individuals within different subgroups into different patches due to behavioral changes.
The goal of the study is to determine how such mobility of individuals within the different patches
will affect interventions either those targeting individuals behavior or those aimed at curtailing the
disease transmission and spread. Note, that we have not aimed to study the impact of movement on
disease spread.
The result shows that when we control risky behaviors either by the use of programs like the
clean needle exchange or encourage individuals to enter drug rehabilitation programs, we are able
to reduce the disease but not eliminate the disease regardless of the connections between the regions.
We see a substantial reduction in isolated patches unlike when the patches are connected, and we were
doing a targeted control in one area at a time. These results agree with existing research [28–30] which
note that only a 25% to 40% partial reduction of HIV transmission risk among IDUs can be obtained
from interventions which focus solely on individual behavioral change. However, some combination
of individually oriented interventions may further reduce the incidence of HIV among IDUs but not
completely eliminate it [30,31].
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Mobility of individuals plays a vital role in the spread of communicable disease. The movement
of individuals to an area increases the likelihood of disease occurrence. Population movement and
mixing is one of the critical factors identified in the social structural production of HIV risk associated
with drug injecting behaviors [30]. Furthermore, movement of IDUs within social network significantly
increases the likelihood of their risky injection drug use behavior over time [32]. For instance, transient
individuals due to homelessness play a role in the spread of HIV among IDUs as these individuals
were more likely to engage in risky behaviors and sharing of needles and going to a shooting gallery
than non-transient individuals [33]. These residential transients often have more than one sleeping
locations and a higher chance of syringe sharing [34].
Hence, it is not surprising to see the results from our sensitivity analysis which showed high
sensitivity indices for parameters associated with the large metropolitan areas which have a high flow
of individuals into it. Although, our model assumes that all individuals from one local to another have
the same mobility rates regardless of their behavior. Recall that the large metropolitan area has a large
number of people compared to the rural area. This result implicitly aligns with Hoffmann et al. [32],
even though we have used a deterministic model unlike the network model used by Hoffmann et al.
The mobility of injection drug users is a key mechanism for the introduction of both IDUs and
infectious diseases into low prevalence areas [35–37]. The disease flow is usually from urban centers
into rural areas; these rural localities often lack adequate disease prevention and harm reduction
services [35,38,39]. Figure 4 shows the migration rate from the larger Shawnee county to the smaller
Jefferson county, a county with fewer residents. Although the rural to urban migration has a higher
flow of migrating individuals, we still see a flow from the larger county to the smaller county which
will impact the distribution of the disease in the smaller county.
Accessing the effect of the intervention on MRSA transmission in our current study shows
a considerable reduction in infection level when each patch implements disease control strategies,
see Figure 10. Since there is this backward flow of individuals into the rural area from the larger
populated metropolitan and suburban areas, it is not surprising to see the effect of this control trickling
into the rural area leading to a noticeable reduction in the number of infection in the rural areas as
risky behavior is being controlled in a large metropolitan and suburban areas. Even though these rural
communities do not have infrastructures to deal with the disease spread and rehabilitation [35,38,39].
From our study, we see that the effect of the control in the rural area is hardly felt in the large metro
and suburban areas. This might be due to the overall people migrating. However, we see a stronger
effect in the rural area when both control strategies (i.e., control behavior and disease) are implemented
in one area at a time; first in the metropolitan area then in the suburban area, see Figure 12. The effect
in the metro area is stronger than the suburban area.
Thus, top-down rather than the bottom-up approach in targeting MRSA in the community with
IDUs is a better strategy to controlling the disease in rural communities that might be struggling with
resources or are in hard to reach places. As the effect of the treatment either behavioral or disease
control will trickle down to surrounding smaller communities from larger communities implementing
such controls. The same cannot be said for the reverse bottom-up approach as the effect of the
interventions is only local to the rural area.
An underlining assumption in this study is that individuals have stable housing structures once
they migrate from one locale to the other. As earlier noted, homeless transients often have more than
one sleeping locations which might increase and encourage needle sharing practices and behaviors.
In future studies, we will investigate the effect of transient mobility due to homelessness and the
impact of various interventions on disease transmission and spread.
6. Conclusions
In this study, we investigated the effect of the mobility of individuals within different regions on
control interventions either those targeting individuals behavior or those aimed at curtailing the disease
transmission. We used an extended version of the model developed in [14] to include the movement
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of individuals between different regions. The model also includes the movement of individuals within
different subgroups into different regions. We itemize our results below.
(1) Sensitivity analysis using LHS and PRCC shows that
(i) Isolated communities have the same sensitivity index;
(ii) Connected communities have different sensitivity index, the large metro area with the
highest movement rates have the highest sensitivity index;
(2) The parameter with the highest impact are related to positive change in behavior (αXi ),
transmission probability (βXi), and recovery (γxi) rates in each group of each connected
communities;
(3) In controlling risky behaviors and MRSA among IDUs we observed that
(i) Controlling risky behaviors or MRSA in isolated areas can substantially reduce MRSA in the
communities;
(ii) Controlling risky behavior or MRSA in the large metro area trickles to other connected areas,
(iii) Interventions implemented in the large metropolitan areas have the strongest impact on the
disease spread followed by suburban area;
(iv) Inventions in the rural area have no effect on the other connected areas;
(4) The disease can be eliminated if both MRSA and behavior are controlled in the communities
whether isolated or connected
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Appendix A. Analysis of the Model
Appendix A.1. Basic Qualitative Properties
Appendix A.1.1. Positivity and Boundedness of Solutions
For the MRSA transmission model Equation (1) with IDUs to be epidemiologically meaningful,
it is vital to show that all the model’s state variables are non-negative for all time. In other words, we
show that the solutions of the model system Equation (1) with non-negative initial data will remain
non-negative for all time t > 0.
Lemma A1. Let the initial data F(0) ≥ 0 , where F(t) = (UNi , CNi , INi , ULi , CLi , ILi , UHi , CHi , IHi ). Then the
solutions F(t) of the MRSA model Equation (1) with IDUs are non-negative for all t > 0. Furthermore
lim sup
t→∞
N(t) =
π
µ
,
where N = NM + NS + NR, π = πNi + πLi + πHi , i = M, S, R, and µ = µM + µS + µR.
Proof. Let t1 = sup{t > 0 : F(t) > 0 ∈ [0, t]}. Thus, t1 > 0. It follows from the first equation of the
system, Equation (1), that
dUNi
dt
= πNi + αLi ULi + τNi CNi + γNi INi − λNi UNi − k1i UNi −
R
∑
j=S, j 6=i
ψijUNi +
R
∑
j=S, j 6=i
ψjiUNj
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which can be re-written as
d
dt
{
UNi (t) exp
[( ∫ t1
0
λNi (ζ)dζ + k1i t +
R
∑
j=S, j 6=i
ψijt
)]}
=
(
πNi + αLi ULi + τNi CNi + γNi INi +
R
∑
j=S, j 6=i
ψjiUNj
)
× exp
[( ∫ t1
0
λNi (ζ)dζ + k1i t +
R
∑
j=S, j 6=i
ψijt
)]
,
where λNi (ζ) =
βNi (CNi (ζ) + INi (ζ) + CLi (ζ) + ILi (ζ) + CHi (ζ) + IHi (ζ))
Ni(ζ)
and k1i = ωNi + µi. Hence,
UNi (t1) exp
[( ∫ t1
0
λNi (ζ)dζ + k1i t1 +
R
∑
j=S, j 6=i
ψijt1
)]
−UN(0)
=
∫ t1
0
(
πNi + αLi ULi (p) + τNi CNi (p) + γNi INi (p) +
R
∑
j=S, j 6=i
ψjiUNj(p)
)
× exp
[( ∫ p
0
λNi (ζ)dζ + k1i p +
R
∑
j=S, j 6=i
ψij p
)]
dp
so that,
UNi (t1) = UN(0) exp
[
−
( ∫ t1
0
λNi (ζ)dζ + k1i t1 +
R
∑
j=S, j 6=i
ψijt1
)]
+ exp
[
−
( ∫ t1
0
λNi (ζ)dζ + k1i t1 +
R
∑
j=S, j 6=i
ψijt1
)]
×
∫ t1
0
(
πNi + αLi ULi (p) + τNi CNi (p) + γNi INi (p) +
R
∑
j=S, j 6=i
ψjiUNj(p)
)
× exp
[( ∫ p
0
λNi (ζ)dζ + k1i t +
R
∑
j=S, j 6=i
ψij p
)]
dp
> 0.
Similarly, it can be shown that F > 0 for all t > 0.
For the second part of the proof, note that 0 < UNi (t) ≤ Ni(t), 0 < CNi (t) ≤ Ni(t), 0 < INi (t) ≤
Ni(t), 0 < ULi (t) ≤ Ni(t), 0 < CLi (t) ≤ Ni(t), 0 < ILi (t) ≤ Ni(t), 0 < UHi (t) ≤ Ni(t), 0 < CHi (t) ≤
Ni(t), 0 < IHi (t) ≤ Ni(t).
Adding the MRSA model Equation (1) with IDUs across the region i = M, S, R, that is
R
∑
i=M
dNi
dt
=
R
∑
i=M
H
∑
k=N
πki −
R
∑
i=M
µi Ni −
R
∑
i=M
H
∑
k=N
δki Iki −
R
∑
i=M
( S
∑
j=M,j 6=i
ψij Ni
)
+
R
∑
i=M
( S
∑
j=M,j 6=i
ψji Nj
)
.
This gives
R
∑
i=M
dNi(t)
dt
=
R
∑
i=M
πi −
R
∑
i=M
µi Ni(t)−
R
∑
i=M
[ H
∑
k=N
δi Iki
]
, (A1)
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since πi = πNi + πLi + πHi and δi = max(δNi , δLi , δHi ), i = M, S, R, and
−
R
∑
i=M
( S
∑
j=M,j 6=i
ψijNi
)
+
R
∑
i=M
( S
∑
j=M,j 6=i
ψji Nj
)
= 0.
Thus, Appendix Equation (A1) lead to the following
R
∑
i=M
dNi(t)
dt
≤
R
∑
i=M
πi −
R
∑
i=M
µi Ni(t).
Hence
dN(t)
dt
≤ π − µN(t),
where, N(t) = NM(t) + NS(t) + NR(t) , π = πM + πS + πR, and µ = max(µM, µS, µR). This resulted
to in the following
π
µ
≤ lim inf
t→∞
N(t) ≤ lim sup
t→∞
N(t) ≤ π
µ
as required.
Appendix A.1.2. Invariant Regions
The MRSA model Equation (1) with IDUs will be analyzed as follows, the region is assumed to be
biologically-feasible region. Now, consider the feasible region
Ωi ⊂ R9+,
with,
Ωi =
{
(UNi , CNi , INi , ULi , CLi , ILi , UHi , CHi , IHi ) ∈ R
9
+ : Ni(t) ≤
πi
µi
}
.
Lemma A2. The region Ωi ⊂ R9+ is positively-invariant for the MRSA model Equation (1) with IDUs with
non-negative initial conditions in R9+.
Proof. The following steps are followed to establish the positive invariance of Ωi (i.e., solutions in Ωi
remain in Ωi for all t > 0). The rate of change of the total human populations is obtained by adding
the equations of the model Equation (1) over a particular region is given as
dNi(t)
dt
=
H
∑
k=N
πki − µi Ni −
H
∑
k=N
δki Iki −
S
∑
j=M, j 6=i
ψijNi +
S
∑
j=M, j 6=i
ψji Nj, (A2)
This reduces to
dNi(t)
dt
≤
H
∑
k=N
πki − µi Ni −
S
∑
j=M, j 6=i
ψijNi +
S
∑
j=M, j 6=i
ψji Nj, (A3)
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From Appendix Equation (A3), and using a standard comparison theorem [40], we can show that
Ni(t) = Ni(0)e
−(µi+∑Sj=M,j 6=i ψij t) +
∑Hk=N πki + ∑
S
j=1,j 6=i ψji Nj(t)
µi + ∑Sj=M,j 6=i ψij
[1− e−(µi+∑
S
j=M,j 6=i ψij t)]. In particular,
Ni(t) =
∑Hk=N πki + ∑
S
j=M,j 6=i ψji Nj(t)
µi + ∑Si=M,i 6=j ψij
, if Ni(0) =
∑Hk=N πki + ∑
S
j=M,j 6=i ψji Nj(t)
µi + ∑Si=M,i 6=j ψij
.
Thus, the region Ω is positively-invariant. Hence, it is sufficient to consider the dynamics of the
flow generated by Equation (1) in Ω. In this region, the model is epidemiologically and mathematically
well-posed [19]. Thus, every solution of the basic model Equation (1) with initial conditions in Ω
remains in Ω for all t > 0. Therefore, the ω-limit sets of the system Equation (1) are contained in Ω.
This result is summarized below.
In the next section, we state the conditions for the existence and stability of the disease-free
equilibrium of the MRSA model Equation (1).
Appendix A.2. Existence and Stability of Disease-Free Equilibrium (DFE)
Lemma A3. The MRSA model Equation (1) with IDU and mobility always has a unique disease-free
equilibrium E0.
Proof. To obtain the DFE of the model Equation (1), we consider the following linear system
πNi + αLi ULi − k1i UNi −
R
∑
j=S, j 6=i
ψijUNi +
R
∑
j=S, j 6=i
ψjiUNi (A4)
πLi + ωNiUNi + αHiUHi − k4i ULi −
R
∑
j=S, j 6=i
ψijULi +
R
∑
j=S, j 6=i
ψjiULi
πHi + ωLi ULi − k7i UHi −
R
∑
j=S, j 6=i
ψijUHi +
R
∑
j=S, j 6=i
ψjiUHi
where,
k1i = ωNi + µi, k4i = ωLi + αLi + µi, k7i = αHi + µi, i = M, S, R
or the system
CU = Π,
where U∗ = (UNM , ULM , UHM , UNS , ULS , UHS , UNR , ULR , UHR)
T , Π = (πNM , πLM , πHM , πNS , πLS , πHS ,
πNR , πLR , πHR)
T , and C = [C1|C2] with
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C1 =

k1M + ∑
R
j=S, j 6=i ψij −αLM 0 −ψSM 0
−ωNM k4M + ∑
R
j=S, j 6=i ψij −αHM 0 −ψSM
0 −ωLM k7M + ∑
R
j=S, j 6=i ψij 0 0
−ψMS 0 0 k1S + ∑
R
j=M, j 6=i ψij −αLS
0 −ψMS 0 −ωNS k4S + ∑
R
j=M, j 6=i ψij
0 0 −ψMS 0 −ωLS
−ψMR 0 0 −ψSR 0
0 −ψMR 0 0 −ψSR
0 0 −ψMR 0 0

,
C2 =

0 −ψRM 0 0
0 0 −ψRM 0
−ψSM 0 0 −ψRM
0 −ψRS 0 0
−αHS 0 −ψRS 0
k7S + ∑
R
j=M, j 6=i ψij 0 0 −ψRS
0 k1R + ∑
S
j=M, j 6=i ψij −αLR 0
0 −ωNR k4R + ∑
S
j=M, j 6=i ψij −αHR
−ψSR 0 −ωLR k7R + ∑
S
j=M, j 6=i ψij

The matrix C involves the travel of susceptibles; it is irreducible and has positive column which
sums respectively to µM, µS, µR according to the corresponding patch. The matrix C has a negative
off-diagonal entries and is thus a non-singular M-matrix [41]; therefore C−1 ≥ 0. Hence, the linear
system of Appendix Equation (A4) has a unique positive solution
U∗ = (U∗NM , U
∗
LM , U
∗
HM , U
∗
NS , U
∗
LS , U
∗
HS , U
∗
NR , U
∗
LR , U
∗
HR)
T = C−1Π > 0
for all U∗Xi , X = N, L, H, i = M, S, R. Hence, the model Appendix Equation (A4) has a unique
disease-free equilibrium
E0 = (U∗NM , 0, 0, U
∗
LM , 0, 0, U
∗
HM , 0, 0, U
∗
NS , 0, 0, U
∗
LS , 0, 0, U
∗
HS , 0, 0, U
∗
NR , 0, 0, U
∗
LR , 0, 0, U
∗
HR , 0, 0).
Thus, this shows that the DFE always exists and is unique.
Next, we consider the local stability of the DFE, E0, for the MRSA model Equation (1). The stability
of E0 can be established using the next generation operator method on the system of Equation (1). Taking
CNi , INi , CLi , ILi , CHi , IHi , as the infected compartments, then using the notation in [20], the Jacobian
matrices F and V for the new infection terms and the remaining transfer terms are respectively given by,
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F =

F11 0 0
0 F22 0
0 0 F22
 and V =

V11 V12 V13
V21 V22 V23
V31 V32 V33

where 0 is a 6 block matrix of zeros,
Fii =

βNi βNi βNi βNi βNi βNi
0 0 0 0 0 0
βLi βLi βLi βLi βLi βLi
0 0 0 0 0 0
βHi βHi βHi βHi βHi βHi
0 0 0 0 0 0

, Vii =

K2 0 −αLi 0 0 0
−σNi K3 0 −αLi 0 0
−ωNi 0 K5 0 −αHi 0
0 −ωNi −σLi K6 0 −αHi
0 0 −ωLi 0 K8 0
0 0 0 −ωLi −σHi K9

,
where
K2 = τNi + k2i +
R
∑
j=M,j 6=i
ψij, K3 = k3i +
R
∑
j=M,j 6=i
ψij,
K5 = τLi + k5i +
R
∑
j=M,j 6=i
ψij, K6 = k6i +
R
∑
j=M,j 6=i
ψij,
K8 = τHi + k8i +
R
∑
j=M,j 6=i
ψij, K9 = k9i +
R
∑
j=M,j 6=i
ψij
V12 = −diag[ψSM, ψSM, ψSM, ψSM, ψSM, ψSM]
V13 = −diag[ψRM, ψRM, ψRM, ψRM, ψRM, ψRM]
V21 = −diag[ψMS, ψMS, ψMS, ψMS, ψMS, ψMS]
V23 = −diag[ψRS, ψRS, ψRS, ψRS, ψRS, ψRS]
V31 = −diag[ψMR, ψMR, ψMR, ψMR, ψMR, ψMR]
V32 = −diag[ψSR, ψSR, ψSR, ψSR, ψSR, ψSR].
It follows that the basic reproduction number of the system of Equation (1), denoted by R0, is
given by
R0 = ρ(FV−1)
where ρ is the spectral radius. Hence, using Theorem 2 in [20], the following result is established.
Lemma A4. The disease-free equilibrium (E0) of the MRSA model Equation (1) with IDUs and mobility is
locally asymptotically stable (LAS) ifR0 < 1 and unstable ifR0 > 1.
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